MedTrace Logo

Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration

NCT02125825 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2016-01-12

No results posted yet for this study

Summary

The objective is to assess a compact, portable, wireless movement disorder system with continuous monitoring capabilities to detect and quantify the severity of levodopa-induced dyskinesia in Parkinson's disease.

Conditions

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Rochester

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • Great Lakes NeuroTechnologies Inc.

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02125825 on ClinicalTrials.gov